CHB Investment Group LLC Makes New $3.03 Million Investment in The Allstate Co. (NYSE:ALL)

CHB Investment Group LLC purchased a new position in shares of The Allstate Co. (NYSE:ALL - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,997 shares of the insurance provider's stock, valued at approximately $3,034,000. Allstate accounts for approximately 1.6% of CHB Investment Group LLC's holdings, making the stock its 17th largest holding.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ALL. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Allstate by 1.8% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 34,808 shares of the insurance provider's stock worth $6,601,000 after buying an additional 621 shares during the last quarter. Trust Co. of Vermont increased its holdings in shares of Allstate by 0.6% in the third quarter. Trust Co. of Vermont now owns 25,389 shares of the insurance provider's stock valued at $4,815,000 after purchasing an additional 161 shares during the period. Bleakley Financial Group LLC lifted its holdings in shares of Allstate by 3.1% during the third quarter. Bleakley Financial Group LLC now owns 5,840 shares of the insurance provider's stock worth $1,108,000 after purchasing an additional 173 shares during the period. Global Retirement Partners LLC grew its position in Allstate by 12.0% in the 3rd quarter. Global Retirement Partners LLC now owns 2,674 shares of the insurance provider's stock valued at $507,000 after buying an additional 286 shares during the last quarter. Finally, Good Life Advisors LLC increased its stake in Allstate by 9.2% in the 3rd quarter. Good Life Advisors LLC now owns 3,960 shares of the insurance provider's stock valued at $751,000 after buying an additional 334 shares during the period. Hedge funds and other institutional investors own 76.47% of the company's stock.

Insider Buying and Selling at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the business's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company's stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 192,530 shares of company stock worth $34,967,665. Corporate insiders own 1.80% of the company's stock.

Allstate Price Performance

Shares of Allstate stock traded down $0.07 during trading on Friday, hitting $195.44. 1,051,562 shares of the company were exchanged, compared to its average volume of 1,548,418. The firm has a 50 day moving average price of $186.17 and a 200 day moving average price of $173.64. The stock has a market capitalization of $51.58 billion, a price-to-earnings ratio of 43.13, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. The Allstate Co. has a fifty-two week low of $121.70 and a fifty-two week high of $198.79.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion for the quarter, compared to the consensus estimate of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business's revenue was up 12.4% on a year-over-year basis. During the same period in the prior year, the business earned ($4.42) earnings per share. On average, equities analysts expect that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. Bank of America boosted their target price on Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a research report on Friday. Raymond James lifted their price target on Allstate from $205.00 to $220.00 and gave the company a "strong-buy" rating in a research note on Friday, October 4th. Jefferies Financial Group upped their price objective on Allstate from $217.00 to $231.00 and gave the stock a "buy" rating in a report on Wednesday, October 9th. Finally, Roth Mkm restated a "buy" rating and set a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. One analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $202.59.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.